1,646 filings
6-K
AZN
Astrazeneca plc
11 Apr 24
Result of Agm
1:22pm
6-K
AZN
Astrazeneca plc
11 Apr 24
Astrazeneca Increases 2024 Dividend by 7%
6:55am
6-K
AZN
Astrazeneca plc
8 Apr 24
Enhertu Approved In Us for HER2+ Solid Tumours
6:14am
6-K
AZN
Astrazeneca plc
5 Apr 24
Imfinzi Improved Os & PFS In Limited-stage SCLC
6:22am
6-K
AZN
Astrazeneca plc
2 Apr 24
Total Voting Rights
1:22pm
6-K
bkoef3 k0l
2 Apr 24
Voydeya Approved In Us
8:45am
6-K
e8plspili
2 Apr 24
Fda Accepts Dato-dxd Bla for Breast Cancer
7:54am
6-K
2jp8b6438
25 Mar 24
Ultomiris Approved In the Us for Nmosd
7:28am
DFAN14A
9e50t
19 Mar 24
Additional proxy materials by non-management
5:27pm
F-3ASR
tfq55byc ewq
19 Mar 24
Automatic shelf registration (foreign)
4:31pm
6-K
9xxj7e50
19 Mar 24
Current report (foreign)
6:02am
6-K
mrggn6xg2siklh3e
14 Mar 24
Astrazeneca to Acquire Amolyt
7:12am
6-K
pdc fbwtprhj27g
12 Mar 24
Director/pdmr Shareholding
7:29am
6-K
v1c8vrhbgu 9ady6
7 Mar 24
Current report (foreign)
6:34am
6-K
1traojyijf04 m1fkgz8
7 Mar 24
Notice of Agm
6:30am
6-K
a4fs2ghe
6 Mar 24
Director/pdmr Shareholding
10:11am
6-K
yyi03uqbjz8s0
6 Mar 24
Director/pdmr Shareholding
10:06am
CERT
43a8ky2h npme1
6 Mar 24
Certification of approval for exchange listing
7:21am
8-A12B
empntomlgjhruzq
5 Mar 24
Registration of securities on exchange
4:40pm
6-K
t2ba6f5l3ipv ad0saj2
4 Mar 24
Ema Validates Dato-dxd Maas for NSQ NSCLC and BC
6:33am